Focus and Vision of ALNET
1) To better understand the action of the lymphatic system in health and disease using advanced imaging technologies, novel bioassays, nanotechnology and cutting edge “omics” technologies.
2) To translate research findings to the clinic through improved imaging, diagnostics, treatment and outcomes for patients suffering from lymphedema.
3) To establish Alberta as a world leader in the fields of lymphatic research and lymphedema treatment.
4) To train future clinicians and researchers interested in lymphatic disease.
The long-term goal of ALNET is to eliminate lymphedema as a chronic health condition.